Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Philip Morris shares soar on strong third quarter

(Reuters) -Philip Morris International’s (PMI) (N:PM) shares hit record highs on Tuesday after the cigarette maker raised its annual profit forecast and beat third-quarter estimates thanks to higher prices and strong demand for its smoking alternatives.

PMI has invested billions of dollars in developing substitutes for cigarettes as health-conscious consumers switch to smoking alternatives in some markets, including its IQOS heated tobacco device and ZYN nicotine pouches, which are now a key focus for investors.

U.S. ZYN shipments in the quarter grew 41.4% over the prior-year period, rebounding after supply constraints curtailed rapid growth. The Marlboro maker has been investing to expand production capacity for ZYN, in an effort to meet strong demand.

The company’s flagship heated tobacco device, IQOS, also saw strong growth in regions such as Japan, Europe and Indonesia, reassuring investors after volumes lagged expectations in the past.

“We delivered exceptionally strong performance, with record quarterly net revenues and earnings per share,” said Chief Executive Officer Jacek Olczak, adding IQOS growth had also accelerated.

PMI’s shares rose 9%, and remained almost 8% higher at 11.43 a.m. (1543 GMT) in New York trading.

The company also enjoyed higher shipment volumes for cigarettes, with higher pricing also driving a 5.2% increase in revenues from its combustible tobacco business.

PMI raised its forecast for 2024 adjusted earnings per share, excluding currency, to between $6.85 and $6.91, compared with its prior range of $6.67 to $6.79.

It reported revenue of $9.91 billion for the third quarter, versus analysts’ estimates of $9.69 billion, according to data compiled by LSEG.

Its quarterly adjusted profit of $1.91 per share also beat estimates of $1.82 per share.

Last week, Philip Morris said it, along with peers British American Tobacco (NYSE:BTI) and Japan Tobacco (OTC:JAPAF), would pay C$32.5 billion ($23.6 billion) to settle long-running health-related lawsuits in Canada.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    Vice President Kamala Harris’s doctor said in a letter Saturday that she is in “excellent health” as she released her first medical report in...

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Donald Trump is leaning into a nativist, anti-immigrant message in the final stage of his third presidential campaign, advancing a closing argument centered on...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com